In last trading session, Cadrenal Therapeutics Inc (NASDAQ:CVKD) saw 0.44 million shares changing hands with its beta currently measuring 1.64. Company’s recent per share price level of $0.49 trading at $0.02 or 5.48% at ring of the bell on the day assigns it a market valuation of $7.85M. That closing price of CVKD’s stock is at a discount of -540.82% from its 52-week high price of $3.14 and is indicating a premium of 26.53% from its 52-week low price of $0.36. Taking a look at company’s average trading volume volume of 288.28K if we extend that period to 3-months.

Cadrenal Therapeutics Inc (NASDAQ:CVKD) trade information

Upright in the green during last session for gaining 5.48%, in the last five days CVKD remained trading in the green while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $0.49 price level, adding 5.79% to its value on the day. Cadrenal Therapeutics Inc’s shares saw a change of -33.71% in year-to-date performance and have moved 13.94% in past 5-day. Cadrenal Therapeutics Inc (NASDAQ:CVKD) showed a performance of -19.34% in past 30-days.

Cadrenal Therapeutics Inc (CVKD) estimates and forecasts

Statistics highlight that Cadrenal Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 14.07% of value to its shares in past 6 months, showing an annual growth rate of 38.18% while that of industry is 12.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

CVKD Dividends

Cadrenal Therapeutics Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.